Study of Huperzine A Sustained-Release Tablets in Patients With Alzheimer's Disease
- First Posted Date
- 2011-01-25
- Last Posted Date
- 2011-01-25
- Lead Sponsor
- Shandong Luye Pharmaceutical Co., Ltd.
- Target Recruit Count
- 390
- Registration Number
- NCT01282619
- Locations
- 🇨🇳
Shanghai Mental Health Center, Shanghai, Shanghai, China
A Clinical Trial of a Radiation Sensitizer in Radiochemotherapy for Thoracic Esophageal Squamous Carcinoma
- First Posted Date
- 2008-03-25
- Last Posted Date
- 2008-05-14
- Lead Sponsor
- Shandong Luye Pharmaceutical Co., Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT00642239
- Locations
- 🇨🇳
Cancer Center of Sun Yat-sen University, Guangzhou, Guangdong, China
🇨🇳Beijing Cancer Hospital, Beijing, Beijing, China
🇨🇳Zhongshan Hospital of Fudan University, Shanghai, Shanghai, China
China Cimicifuga Trial of Climacteric Complaint Control
Phase 4
- Conditions
- Climacteric Symptoms
- Interventions
- Drug: an extract of Cimicifuga Foetida L.Drug: placebo
- First Posted Date
- 2008-02-25
- Last Posted Date
- 2008-02-25
- Lead Sponsor
- Shandong Luye Pharmaceutical Co., Ltd.
- Target Recruit Count
- 288
- Registration Number
- NCT00622986
- Locations
- 🇨🇳
Daping Hospital, Chongqing, China
🇨🇳Fujian Provincal Maternal and Children Health Hospital, Fuzhou, Fujian, China
🇨🇳Shandong Provincial Hospital, Jinan, Shandong, China
Pharmacokinetics Study of Liposomal Paclitaxel in Humans
- First Posted Date
- 2008-02-04
- Last Posted Date
- 2009-02-10
- Lead Sponsor
- Shandong Luye Pharmaceutical Co., Ltd.
- Target Recruit Count
- 16
- Registration Number
- NCT00606515
- Locations
- 🇨🇳
Cancer Hospital of Fudan University, Shanghai, China
© Copyright 2025. All Rights Reserved by MedPath